SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-085391
Filing Date
2020-07-22
Accepted
2020-07-22 07:00:23
Documents
5
Period of Report
2020-07-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2025362-1_8k.htm 8-K 20039
2 EXHIBIT 99.1 tm2025362d1_ex99-1.htm EX-99.1 19699
3 GRAPHIC tm2025362d1_ex99-1img001.jpg GRAPHIC 23402
4 GRAPHIC tm2025362d1_ex99-1img002.jpg GRAPHIC 24369
5 GRAPHIC tm2025362d1_ex99-1img003.jpg GRAPHIC 31280
  Complete submission text file 0001104659-20-085391.txt   150306
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37526 | Film No.: 201040249
SIC: 2834 Pharmaceutical Preparations